UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Aravive is implementing good security practices.
Aravive, Inc., is a clinical stage biotechnology company focused on developing new therapies that target important survival pathways for both solid tumors as well as hematologic malignancies.
This report shows a preliminary security rating for Aravive. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Internet Protocol (IP) attribution is the attempt to identify a device ID or individual responsible ...
The OWASP Top 10 is a regularly-updated report outlining the top 10 list of security concerns for ...
Compare Aravive's security performance with other companies